• Micro-Computed Tomography ( CT) imaging of the cochlea during in vivo infusion of a contrast agent at the basal end of scala tympani through a cochleostomy.
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• Micro-Computed Tomography ( CT) imaging of the cochlea during in vivo infusion of a contrast agent at the basal end of scala tympani through a cochleostomy.
• 3-D Registration: Cochlear atlas geometrically transformed to the CT images using a cascade of transformations with transfer of atlas labels to the scans to delineate cochlear structures.
• Spatio-temporal concentration extraction from the CT images for each of the major scala (scala tympani, scala vestibuli, scala media).
• Learning-Prediction model: Learning concentration dependent diffusion coefficient, transport parameters between major scalae and to clearance to enable forward simulation of cochlear pharmacokinetics.
[19, 20, 21 ] assessment of gadolinium distribution within the cochlea following transtympanic injection in humans 23 and application to the round window membrane niche in guinea pigs. However, resolution limitations preclude use 24 of MRI for high fidelity pharmacokinetic analysis, especially in smaller rodents such as the mouse with total cochlear 25 length less than 7mm.
26
In order to enable intracochlear pharmacokinetic analysis in mice via high resolution imagery, the use of contrast-enhanced 27 micro computed tomography (µCT) was first introduced by Haghpanahi and colleagues [22] . CT works on the basic 28 principle of combination of X-ray attenuation measurements (attenuation coefficients) taken from multiple angles, 29 usually in a cylinder, sphere, or helix around the object, to obtain a volume consisting of slices (tomograms) in each 30 of the three orthogonal dimensions [23] . µCT is similar to the CT scanners used in medical facilities, but the scale of M A N U S C R I P T The cochleostomy experiments were carried out on a total of 17 animals, and were used to test the 3-D image registration 111 algorithms. Of the 17 animals, three were used for final contrast agent infusion for purposes of quantitative pharmacokinetic 112 model development and learning of diffusion and transport parameters. These specific experiments achieved minimal 113 or no leakage at the cochleostomy site with expected rapid increases in basal contrast agent concentration. As described 
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PROCESSING AND EXTRACTION
118
After the scans are obtained post-surgery, we proceed to convert the scans to the required format, register the scans,
119
and extract the concentration from the three main scalae as explained below. 
µCT Calibration for Contrast Agent Concentration
135
The values associated with voxels in a µCT scan are in Hounsfield units (HU), which is a linearly transformed version 136 of linear attenuation coefficients, shifted and scaled so that the radiodensities of distilled water and air at standard 137 temperature and pressure are defined to be 0 HU and -1000 HU, respectively. To transform from HU to units of 138 concentration (mg/ml), we carried out a calibration procedure similar to that defined in [22] . We placed seven pipet 139 tips filled with contrast agents at 50, 100, 150, 200, 240, 370 (mg/ml) Iopamidol in a custom 3-D printed holder 140 along with a pipet tip filled with saline (reference solution for 0 mg/ml). These are then imaged in the same µCT 141 scanner using settings identical to those used during the animal experiments. After the images are obtained, the 142 procedure to fit the HU values to the concentration in mg/ml, and finding sensitivity cutoff is adopted from our previous 143 work in [22] . The average HU value for the entire volume of each pipet are plotted against the Iopamidol concentrations, cutoff of 2.655 mg/ml was obtained using the standard deviation of HU values of each pipet using the methods described 148 in [22] . The sensitivity cutoff is the value below which Iopamidol concentrations cannot be resolved above the noise.
149
Average of concentrations taken in a circular window in the calibration scans with diameters ranging from 1 to 15
150
showed that the variation in concentration decreased below the sensitivity cutoff value when a 7 diameter or above 151 circular window was chosen. To prevent the averaging window from including bone at the scala walls, we chose to is chosen over the µCT scans for resampling due to its higher resolution, and to avoid introducing artifacts into the 168 µCT scans that can alter the contrast agent concentrations to be extracted. 
3-D Registration and Segmentation
170
To solve the problem of segmenting the three major scalae in the cochlea, an atlas based registration approach is 171 implemented in C++ using the Insight Toolkit library [32] . In this approach, the cochlear atlas is geometrically 172 transformed using a cascade of transformations so that it optimally aligns with the ROI extracted from the current 
For the cost function, we employ the negative correlation coefficient between the image data; i.e.
193
F I m (τ),
where I f i is the i th voxel of fixed image, I mi is the i th voxel of moving image, and N is the number of voxels in the We define the criterion for terminating the optimization procedure to be when the step length between two consequent 204 iterations is less than or equal to 10 −6 .
205
Using this final transformationτ, the label maps are transferred into the geometry of the µCT scans. Although we 206 restrict our analysis to the three main scalae and SL,τ can be applied to any number of regions that exist in the for the infused cochlea is extracted from each scan and stored in NIFTI format. A Similarity and Affine registration is done against the resampled Atlas images [1] , followed by a 3-D deformable B-spline registration. The affine registration ensures that we have a good atlas starting point for the B-spline registration. The segments are then separated into ST, SV, SM and SL, and because the SL is only 2 to 8 voxel thick, it is omitted from further processing. Given the segmented regions, the medial axis is calculated and re-parameterized in terms of arclength. Intensities (Hounsfield units) from 7 voxel diameter discs are averaged at every 1% point along the medical axis for each scalae in each scan. Intensities are converted to concentration (mg/ml) based on a pre-determined calibration curve. for SV, cuts the SM medial axis, which is picked as the zero point in SM. The ending points of all three scalae are 224 chosen to be the final point at the apex in the medial axis that can be visually discerned.
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225
The final medial axis is defined in terms of a discrete set of voxels. In order to extract a robust estimate of the concentration 226 from the scalae, we define the concentration at each medial axis location as the average of concentrations in a plane 227 through that medial axis location and normal to the medial axis. Normal planes are obtained by defining a differentiable
228
Figure 6: Example of medial axis extraction from an ST label map. A is the label map obtained from the registration and segmentation process. B is the label map after morphological thinning is applied. The thinned label map still contains stray branches (red arrow) off of the medial axis that are removed in the subsequent pruning process, which yields the right-most label map. It can be observed that the round window membrane (RWM) branches are missing from the final medial axis owing to the fact that we consider zero-point of ST for concentration extraction after the round window branch, near the cochleostomy site. C represents the resulting medial axis.
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curve through the discrete set of voxels on the medial axis and by identifying the normal and binormal vectors to the 229 curve. Cubic splines provide a mechanism for defining such a differentiable curve; a series of three cubic splines are 230 fit to the three components of the medial axis, and then the cubic splines are reparametrized in terms of arc length.
231
This re-parameterization serves two purposes: the continuous curve can be used to divide the scala equally, and 
PHARMACOKINETIC MODELING
240
The spatio-temporal concentration profiles that are extracted for the ST, SV, and SM can be used to estimate diffusion 
263
ST: CO to CA :
ST: CO to apex :
SM :
SV :
The diffusion coefficient D is assumed to be the same for all the three compartments. For a solute molecule with 264 molecular weight MW and viscosity of the solution η, the theoretical diffusion coefficient is defined as:
13 M A N U S C R I P T 
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Where, C(n) is the estimated concentration averaged over 20 minutes at n th point on the scala, so that it can be compared 286 to the corresponding concentration extracted from the scans. 
Estimating Diffusion and Transport Parameters
288
To estimate contact area between scalae, morphological dilation is used to find the region of intersection between we make use of the SM and SV label maps to obtain contact area between them. For the transport from SM-clearance,
293
the intersection are between SM-SL is calculated similarly using morphological dilation. Eq. 5 to 7, take the area of to random values between 0 and 1, and iteratively learnt using optimization. and the loss is calculated using mean squared loss cost function.
Where, C sim (n) is the averaged simulated concentration, C scan (n) is the extracted concentration from the respective 
As shown in Fig. 8 , the gradient for each parameter is multiplied by their respective learning rate, and subtracted rate is initialized to low values in the range of 10 −2 to 10 −3 and they remain unchanged till the end of optimization.
317
The optimization continues until the change in loss is less than 0.01%.
318
The transport parameters are initially learnt by keeping a constant flow rate profile with respect to time F in eq. are then re-learned using the new flow rate profile that accounts for time-varying leakage at the cochleostomy site.
328
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RESULTS
329
This work involved 17 animal experiments, out of which all the experiments were used to test and refine the registration 330 and segmentation algorithms. Iopamidol infusions from three experiments were used for determination of transport 331 parameters, and for development and testing of the pharmacokinetics model. in Fig. 9 . The region outside the cochlea is empty in the atlas, whereas it is filled with various tissues in the scans 341 resulting in lower Jaccard index. Moreover, due to variation in cochlea of animal used in atlas compared to animals 342 used in our experiment, there will be inaccuracies in the registration result. Figure 10: The curves represent the normalized diffusion coefficient as a function of concentration based on the extracted γ parameter for each experiment.
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Extracted and Simulated Concentrations
344 Table 1 
Where, molecular weight and density of the 1st molecule (MW 1 , ρ 1 ), and the 2nd molecule (MW 2 , ρ 2 ) are known quantities. Similarly, transport coefficients K are scaled using the same relationship as eq. 15 as shown below.
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where K 2 , and K 1 represent the transport coefficients for the 2 nd and 1 st molecule respectively.
482
A key limitation of the presented work is that the molecules which can be quantified are limited to those exhibiting 483 image contrast for µCT imaging. There are a wide range of triiodo compounds that can be imaged, however translation 
